72
Views
6
CrossRef citations to date
0
Altmetric
Review

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases

, , &
Pages 123-128 | Published online: 14 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Philip G. Conaghan, Dorothy L. Keininger, Elizabeth A. Holdsworth, Nicola Booth, Niraj N. Modi, Haijun Tian & Uta Kiltz. (2021) Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries. Current Medical Research and Opinion 37:10, pages 1845-1853.
Read now

Articles from other publishers (5)

Shaik SHAFIULLA & Suneela DHANESHWAR. (2022) Recent Advancements in Antipsoriatic Therapy: An Update. Fabad Journal of Pharmaceutical Sciences, pages 83-108.
Crossref
Devy Zisman, Mirna Safieh, Elina Simanovich, Joy Feld, Amalia Kinarty, Liron Zisman, Tal Gazitt, Amir Haddad, Muna Elias, Itzhak Rosner, Lisa Kaly & Michal A. Rahat. (2021) Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147. Frontiers in Immunology 12.
Crossref
O. A. Pritulo & A. A. Petrov. (2021) Psoriasis and pathological angiogenesis: pathogenetic signifcance and therapeutic perspectives. Medical alphabet:33, pages 58-63.
Crossref
Joan Anak Blin, Roslida Abdul Hamid & Huzwah Khaza’ai. (2021) Bioactive fractions and compound of Ardisia crispa roots exhibit anti-arthritic properties mediated via angiogenesis inhibition in vitro. BMC Complementary Medicine and Therapies 21:1.
Crossref
Tuhin Mukherjee, Tapan Behl, Aayush Sehgal, Saurabh Bhatia, Harmanpreet Singh & Simona Bungau. (2021) Exploring the molecular role of endostatin in diabetic neuropathy. Molecular Biology Reports 48:2, pages 1819-1836.
Crossref